PNC Financial Services Group
XFOR icon

PNC Financial Services Group’s X4 Pharmaceuticals XFOR Stock Holding History

PNC Financial Services Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.21K Hold
1,759
– – ﹤0.01% 4185
2026
Q1 		$7.26K Hold
1,759
– – ﹤0.01% 4094
2025
Q4 		$7.04K Hold
1,759
– – ﹤0.01% 4096
2025
Q3 		$6.02K Sell
1,759
-34
-2% -$88 ﹤0.01% 4137
2025
Q2 		$3.41K Buy
1,793
+758
+73% +$3.1K ﹤0.01% 4250
2025
Q1 		$7.33K Buy
1,035
+30
+3% +$413 ﹤0.01% 3936
2024
Q4 		$22.1K Hold
1,005
– – ﹤0.01% 3486
2024
Q3 		$20.2K Hold
1,005
– – ﹤0.01% 3503
2024
Q2 		$17.5K Hold
1,005
– – ﹤0.01% 3546
2024
Q1 		$41.9K Hold
1,005
– – ﹤0.01% 3078
2023
Q4 		$25.3K Sell
1,005
-7
-0.7% -$170 ﹤0.01% 3304
2023
Q3 		$33.1K Hold
1,012
– – ﹤0.01% 3166
2023
Q2 		$58.9K Hold
1,012
– – ﹤0.01% 2969
2023
Q1 		$26.4K Sell
1,012
-23
-2% -$674 ﹤0.01% 3360
2022
Q4 		$30.8K Hold
1,035
– – ﹤0.01% 3246
2022
Q3 		$53K Buy
1,035
+333
+47% +$11.5K ﹤0.01% 2938
2022
Q2 		$20K Buy
702
+333
+90% +$12.7K ﹤0.01% 3503
2022
Q1 		$19K Buy
369
+24
+7% +$1.38K ﹤0.01% 3606
2021
Q4 		$24K Hold
345
– – ﹤0.01% 3473
2021
Q3 		$55K Hold
345
– – ﹤0.01% 3014
2021
Q2 		$67K Hold
345
– – ﹤0.01% 2889
2021
Q1 		$89K Hold
345
– – ﹤0.01% 2650
2020
Q4 		$67K Hold
345
– – ﹤0.01% 2735
2020
Q3 		$70K Hold
345
– – ﹤0.01% 2534
2020
Q2 		$96K Hold
345
– – ﹤0.01% 2360
2020
Q1 		$104K Hold
345
– – ﹤0.01% 2205
2019
Q4 		$111K Buy
345
+55
+19% +$19.7K ﹤0.01% 2426
2019
Q3 		$111K Buy
290
+33
+13% +$13.1K ﹤0.01% 2478
2019
Q2 		$116K Buy
+257
New +$131K ﹤0.01% 2472

Other funds holding XFOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PNC Financial Services Group's XFOR Position: Q2 2026 in Review

PNC Financial Services Group held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 1,759 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4185.

PNC Financial Services Group first reported a position in XFOR in Q2 2019 and has held it in 29 quarters since. The position peaked at $116K in Q2 2019. 19 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • PNC Financial Services Group held 1,759 shares of X4 Pharmaceuticals worth $8.21K as of Q2 2026.
  • PNC Financial Services Group left its X4 Pharmaceuticals share count unchanged in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4185 holding.
  • PNC Financial Services Group first reported a position in X4 Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
  • PNC Financial Services Group's X4 Pharmaceuticals position peaked at $116K in Q2 2019.
  • 19 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.